LVW Advisors LLC Acquires 69 Shares of HCA Healthcare, Inc. (NYSE:HCA)

LVW Advisors LLC lifted its stake in HCA Healthcare, Inc. (NYSE:HCA) by 1.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,384 shares of the company’s stock after purchasing an additional 69 shares during the period. LVW Advisors LLC’s holdings in HCA Healthcare were worth $1,782,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of HCA. Capital World Investors grew its position in shares of HCA Healthcare by 57.5% in the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock worth $931,342,000 after buying an additional 1,019,750 shares during the period. Lee Danner & Bass Inc. purchased a new position in shares of HCA Healthcare during the second quarter valued at approximately $131,527,000. Darsana Capital Partners LP raised its stake in HCA Healthcare by 53.3% during the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after buying an additional 400,000 shares during the last quarter. Swedbank AB bought a new position in shares of HCA Healthcare during the first quarter valued at $95,882,000. Finally, Wellington Management Group LLP boosted its stake in HCA Healthcare by 1.7% in the 4th quarter. Wellington Management Group LLP now owns 10,186,129 shares of the company’s stock worth $2,757,181,000 after purchasing an additional 170,560 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insiders Place Their Bets

In other news, SVP Kathryn A. Torres sold 1,857 shares of the firm’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the sale, the senior vice president now owns 17,755 shares in the company, valued at approximately $6,303,912.75. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the transaction, the senior vice president now owns 17,755 shares of the company’s stock, valued at $6,303,912.75. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 17,202 shares of company stock valued at $6,407,273 over the last ninety days. 1.60% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on HCA shares. Royal Bank of Canada lifted their target price on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a report on Friday, August 23rd. Cantor Fitzgerald reissued an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a report on Tuesday, October 1st. Leerink Partners lifted their price objective on HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. KeyCorp started coverage on shares of HCA Healthcare in a research note on Friday. They issued an “overweight” rating and a $475.00 price target for the company. Finally, Wells Fargo & Company raised their target price on shares of HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 30th. Five research analysts have rated the stock with a hold rating, fifteen have given a buy rating and three have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $365.65.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock traded up $8.16 during trading hours on Friday, hitting $395.41. The company’s stock had a trading volume of 182,132 shares, compared to its average volume of 1,133,327. The business has a 50 day moving average price of $386.39 and a two-hundred day moving average price of $347.16. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. HCA Healthcare, Inc. has a 12-month low of $215.96 and a 12-month high of $409.42. The company has a market cap of $102.04 billion, a PE ratio of 18.18, a PEG ratio of 1.44 and a beta of 1.67.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, beating the consensus estimate of $4.97 by $0.53. The business had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The business’s revenue was up 10.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $4.29 EPS. Analysts expect that HCA Healthcare, Inc. will post 22.51 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, September 30th. Investors of record on Monday, September 16th were issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date of this dividend was Monday, September 16th. HCA Healthcare’s payout ratio is 12.39%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.